Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Tricida Inc (TCDA)

Tricida Inc (TCDA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tricida Inc 7000 SHORELINE COURT SUITE 201 SOUTH SAN FRANCISCO CA 94080 USA

P: 415-429-7800

Description:

Tricida, Inc. is a late-stage pharmaceutical company. It focuses on the discovery and clinical development of novel therapeutics to address renal, metabolic and cardiovascular diseases. The company's product candidate consists of TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. Tricida, Inc. is based in CA, United States.

Key Statistics

Overview:

Market Capitalization, $K 1,987,993
Shares Outstanding, K 49,613
Annual Sales, $ 0 K
Annual Net Income, $ -102,810 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -44,120 K
60-Month Beta 0.86
% of Insider Shareholders 66.70%
% of Institutional Shareholders 76.47%
Float, K 16,521
% Float 33.30%

Growth:

1-Year Return 40.35%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/14/19
Earnings Per Share ttm -3.20
EPS Growth vs. Prev Qtr -18.67%
EPS Growth vs. Prev Year -27.14%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

TCDA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -9.21
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -57.81
Return-on-Assets (Before Tax) -46.22
Profit Margin % N/A
Net Margin % N/A
Debt/Equity 0.11
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 6.29
Book Value/Share 6.31
Interest Coverage -31.74
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar